These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16761129)

  • 1. The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance.
    Silber BY; Croft RJ; Papafotiou K; Stough C
    Psychopharmacology (Berl); 2006 Aug; 187(2):154-69. PubMed ID: 16761129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition.
    Johnson BA; Roache JD; Ait-Daoud N; Wallace C; Wells LT; Wang Y
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):296-302. PubMed ID: 15452681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the sensitivity of the standardised field sobriety tests to detect the presence of amphetamine.
    Silber BY; Papafotiou K; Croft RJ; Stough CK
    Psychopharmacology (Berl); 2005 Oct; 182(1):153-9. PubMed ID: 15986192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute effects of d-amphetamine and d-methamphetamine on ERP components in humans.
    Silber B; Croft R; Camfield DA; Downey LA; Papafotiou K; Stough C
    Eur Neuropsychopharmacol; 2012 Jul; 22(7):492-500. PubMed ID: 22209365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Driving under the influence of amphetamine and metamphetamine].
    Lia K; Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):105-8. PubMed ID: 19151802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute physiological and behavioral effects of intranasal methamphetamine in humans.
    Hart CL; Gunderson EW; Perez A; Kirkpatrick MG; Thurmond A; Comer SD; Foltin RW
    Neuropsychopharmacology; 2008 Jul; 33(8):1847-55. PubMed ID: 17851535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of d-methamphetamine on simulated driving performance.
    Silber BY; Croft RJ; Downey LA; Papafotiou K; Camfield DA; Stough C
    Hum Psychopharmacol; 2012 Mar; 27(2):139-44. PubMed ID: 22389077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals.
    Johnson BA; Roache JD; Ait-Daoud N; Wells LT; Wallace CL; Dawes MA; Liu L; Wang XQ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):123-30. PubMed ID: 16978753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans.
    Kirkpatrick MG; Gunderson EW; Johanson CE; Levin FR; Foltin RW; Hart CL
    Addiction; 2012 Apr; 107(4):783-91. PubMed ID: 22050030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acute effects of 3,4-methylenedioxymethamphetamine and methamphetamine on driving: a simulator study.
    Stough C; Downey LA; King R; Papafotiou K; Swann P; Ogden E
    Accid Anal Prev; 2012 Mar; 45():493-7. PubMed ID: 22269534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine.
    Dalley JW; Lääne K; Theobald DE; Peña Y; Bruce CC; Huszar AC; Wojcieszek M; Everitt BJ; Robbins TW
    Neuropsychopharmacology; 2007 May; 32(5):1195-206. PubMed ID: 17035931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of lisdexamfetamine and D-amphetamine on social cognition and cognitive performance in a placebo-controlled study in healthy subjects.
    Dolder PC; Strajhar P; Vizeli P; Odermatt A; Liechti ME
    Psychopharmacology (Berl); 2018 May; 235(5):1389-1402. PubMed ID: 29511807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
    Leufkens TR; Lund JS; Vermeeren A
    J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of dexamphetamine on simulated driving performance.
    Silber BY; Papafotiou K; Croft RJ; Ogden E; Swann P; Stough C
    Psychopharmacology (Berl); 2005 May; 179(3):536-43. PubMed ID: 15614573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of d-amphetamine on simulated driving performance before and after sleep deprivation.
    Hjälmdahl M; Vadeby A; Forsman A; Fors C; Ceder G; Woxler P; Kronstrand R
    Psychopharmacology (Berl); 2012 Aug; 222(3):401-11. PubMed ID: 22638811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.
    Killgore WD; Rupp TL; Grugle NL; Reichardt RM; Lipizzi EL; Balkin TJ
    J Sleep Res; 2008 Sep; 17(3):309-21. PubMed ID: 18522689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial.
    Thompson RG; Oliveto A; Thostenson JD; Wilson MP; McGaugh J; Mancino MJ
    J Psychopharmacol; 2021 Nov; 35(11):1420-1430. PubMed ID: 34697965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study.
    van de Loo AJAE; Bervoets AC; Mooren L; Bouwmeester NH; Garssen J; Zuiker R; van Amerongen G; van Gerven J; Singh J; der Ark PV; Fedgchin M; Morrison R; Wajs E; Verster JC
    Psychopharmacology (Berl); 2017 Nov; 234(21):3175-3183. PubMed ID: 28755104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.